Exclusive: Two London hospital trusts to trial tool that can predict those at risk up to 13 years before condition develops
The NHS in England is launching a world-first trial of a “gamechanging” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before they develop the condition.
More than 500 million people worldwide have type 2 diabetes, and finding new ways to spot people at risk before they develop the condition is a major global health priority. Estimates suggest 1 billion people will have type 2 diabetes by 2050.
About Author
More Stories
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
New AI test can predict which men will benefit from prostate cancer drug
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip